Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,353.5
-4.2 (-0.13%)

 

  • STI Straits Times Index
    3,353.5
    -4.2 (-0.13%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,627.4
    5.4 (0.33%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,963.2
    -0.0 (-0.00%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,198.6
    -16.4 (-0.51%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,259.7
    41.8 (0.19%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,462.8
    48.1 (0.75%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,220.5
    3.9 (0.17%)
    Index delayed 20 minutes
  • XAO XAO
    6,411.1
    61.2 (0.96%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 768.4M
  • Value: 865.0M
  • Rise: 138
  • Fall: 194
  • Unch: 513

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
ThaiBev0.835+0.005
JCG Investment0.002-
Rex Intl0.081+0.002
Genting Sing0.960-0.010
Nico Steel^0.005-
Mapletree Log Tr1.440-0.010
Sembcorp Marine1.790+0.080
Asian Pay Tv Tr0.174+0.007
Miyoshi0.054-0.002
SingTel3.170-

World Indices

World Indices
Name Last Change
Nasdaq 8,015.3 +17.2
HSI 29,963.2
HSCEI 11,731.0 -37.6
Jakarta 6,462.8 +48.1
Nikkei 225 22,259.7 +41.8
SSE Comp 3,198.6 -16.4
Shanghai A 3,350.2 -17.2
Shanghai B 314.7 -1.5
ShenZhen A 1,808.2 -24.1
ShenZhen B 1,040.6 -7.2
Taiwan W 11,025.7 +38.0
PSE Comp 0.0
KOSPI 2,220.5 +3.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

QT Vascular QT VASCULAR LTD.
Quotes 10 Minutes Delayed. Updated at 23 Apr 2019 17:03
Last (SGD): 0.004 Change: - High: 0.004 Remarks: -
Change (%): - Low: 0.004
Open 0.004 Yesterday's Close 0.004
Buy Price 0.003 Sell Price 0.004
Buy Volume ('000) 59,564.0 Sell Volume ('000) 677.3
Cumulative Volume ('000) 4,250.0 Cumulative Value 17,000
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01923 Trailing EPS (SGD) e 0.01923 NAV (SGD) b 0.0115
PE a 0.208 Trailing PE f 0.208 Price / NAV b 0.3478
Dividend (SGD) d - Cash In Hand (SGD) g 0.0070 Issued & Paid-up Shares c 2,092,632,000
Dividend Yield (%) d - Price / Cash In Hand g 0.571 Treasury Shares h -
Beta - 75 Daysi 3.357 R-Squared - 75 Days(%)i 3.68 Market Cap (M) 8.371
Beta - 500 Daysi 0.958 R-Squared - 500 Days (%)i 0.92 Enterprise Value (M) -3.061
Piotroski F Score 4 Exchange Code 5I0 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 90.2039 6-Month VWAP 0.006 Free Float (%) 92.5
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Biotechnology
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QT Vascular SGX 8.371 0.208 0.208 0.3478 -
Industry Biotechnology SGX 1,984.451 7.329 7.329 0.6875 4.753
Medical & Biotechnology SGX 1,034.370 23.063 23.073 1.4096 1.861
Index FTSE ST Catalist Index SGX 80.799 130.792 - 0.9254 2.252
Local Peer Lonza SGX 5,937.453 7.663 7.663 0.6889 4.766
Local Peer Suntar Eco-City^ SGX 7.531 - - 0.4286 -
Global Peer AMGEN INC NASDAQ 108,628.766 12.941 12.941 8.6903 3.060
Global Peer GILEAD SCIENCES INC NASDAQ 78,878.063 14.460 14.460 3.6881 3.706
Global Peer AMGEN-T HKEx 615,949.000 9.363 9.363 6.2937 4.230
Global Peer CELGENE CORP NASDAQ 65,622.879 16.219 16.219 10.6514 -
Global Peer CSL ASX 86,256.837 38.658 35.407 12.5151 1.197
Global Peer ILLUMINA INC NASDAQ 46,876.555 56.751 56.751 12.4738 -
Global Peer BIOGEN INC NASDAQ 45,008.986 10.158 10.158 3.4517 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 43,083.318 20.551 20.551 9.7139 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 36,501.913 14.933 14.933 4.1682 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 28,925.728 372.749 372.754 3.1560 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), WUXI BIO (HKEx), SINO BIOPHARM (HKEx), EXACT SCIENCES CORP (NASDAQ), SEATTLE GENETICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), MODERNA INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE-B (HKEx), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), TILRAY INC (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), 3SBIO (HKEx), GENSCRIPT BIO (HKEx), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), REPLIGEN CORP (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), UNIQURE N.V. (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ANAPTYSBIO INC (NASDAQ), REGENXBIO INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), SANGAMO THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), HAOHAI BIOTEC (HKEx), EPIZYME INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RADIUS HEALTH INC (NASDAQ), ASCLETIS-B (HKEx), VERACYTE INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), MACROGENICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CHEMOCENTRYX INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), INTREXON CORP (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DERMIRA INC (NASDAQ), CKLIFE SCIENCES (HKEx), STEMLINE THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), SYNTHORX INC (NASDAQ), MESOBLAST LTD (ASX), GLYCOMIMETICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), LEE'S PHARM (HKEx), ACORDA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ESSEX BIO-TECH (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), AVITA MEDICAL LTD (ASX), CYTOKINETICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), TRANSLATE BIO INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), POLYNOVO LIMITED (ASX), MEDICINOVA INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), MERUS B V (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), GERON CORP (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), UNITY BIOTECHNOLOGY INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SAVARA INC (NASDAQ), AGENUS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), XBIOTECH INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), INSYS THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NYSE), SERES THERAPEUTICS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), ADURO BIOTECH INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), KAMADA (NASDAQ), NOVAVAX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), RESTORBIO INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), MERSANA THERAPEUTICS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), ARDELYX INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ATHERSYS INC (NASDAQ), AFFIMED N V (NASDAQ), COMPUGEN (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SYNLOGIC INC (NASDAQ), TOCAGEN INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), VBI VACCINES INC CDA (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NYSE American), BBI LIFE SCI (HKEx), SYNDAX PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), CUE BIOPHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), STANDARD DIVERSIFIED INC (NYSE American), VERASTEM INC (NASDAQ), IMV INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), TELIX PHARMACEUTIC (ASX), PIERIS PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), TREVENA INC (NASDAQ), CHIMERIX INC (NASDAQ), PFENEX INC (NYSE American), ALPINE IMMUNE SCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), UNI-BIO GROUP (HKEx), ITERUM THERAPEUTICS PLC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), XOMA CORP (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), VERMILLION INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), EQUILLIUM INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), COHBAR INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ZAFGEN INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), NANTKWEST INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), MERRIMACK PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), OTONOMY INC (NASDAQ), SESEN BIO INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IBIO INC (NYSE American), GENOCEA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ARAVIVE INC (NASDAQ), PORT (SET), IDERA PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD (ASX), ALIMERA SCIENCES INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), CT ENTERPRISE (HKEx), AQUINOX PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), NEWLINK GENETICS CORP (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), IVERIC BIO INC (NASDAQ), CURIS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CEL-SCI CORP (NYSE American), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIONOMICS LTD (ASX), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), BIONANO GENOMICS INC (NASDAQ), IMUGENE LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), PHYLOGICA LIMITED (ASX), CONTRAFECT CORP (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOTRON (ASX), HEAT BIOLOGICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), SENESTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ONCOMED PHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), EXTRAWELL PHAR (HKEx), SOPHIRIS BIO INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), BIOSINO BIO-TEC (HKEx), ONCOLYTICS BIOTECH INC (NASDAQ), ADVAXIS INC (NASDAQ), GTX INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ATYR PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), VICAL INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BENITEC BIOPHARMA LTD (ASX), APTOSE BIOSCIENCES INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ORAGENICS INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), ONCONOVA THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), RHINOMED LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), PATRYS LIMITED (ASX), COLLPLANT HOLDINGS LTD SPON ADR EACH REP 50 ORD(POST REV SPLT) (NASDAQ), ADALTA LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), HISTOGENICS CORP (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), REGENEUS LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CLEVELAND BIOLABS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), XENETIC BIOSCIENCES INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), ANTEO DIAGNOSTICS LIMITED (ASX), TROVAGENE INC (NASDAQ), ALLIQUA BIOMEDICAL INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), GENETIC TECHNOLOGIES (ASX), CELLMID LIMITED (ASX), SOLIGENIX INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), HAO WEN HLDGS (HKEx), CELLECTAR BIOSCIENCES INC (NASDAQ), AURIS MEDICAL HOLD (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADR EA REPR 2 ORD SHS (NYSE American), ORTHOCELL LIMITED (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), NEURALSTEM INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), MGRC (Bursa), BIOXYNE LIMITED (ASX), PROTEON THERAPEUTICS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), MEMPHASYS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), VAXART INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MEGASUN (Bursa), OHR PHARMACEUTICAL INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), STELLAR BIOTECHNOLOGIES INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), CYTORI THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), PHOSPHAGENICS LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), NANOLLOSE LTD (ASX), MEDIBIO LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX), AMPLIPHI BIOSCIENCES CORPORATION (NYSE American), ALCHEMIA LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), BPH ENERGY LIMITED (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), GENERA BIOSYSTEMS LIMITED (ASX), SINOVAC BIOTECH (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days --0.001
-20.00 %
Medium Term Return 3 Months --0.003
-42.86 %
6 Months --0.007
-63.64 %
1 Year --0.011
-73.33 %
Long Term Return 2 Years --0.026
-86.67 %
3 Years --0.105
-96.33 %
Annualised Return Annualised --
-66.77 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.003 - 0.019 Change From 1 Year Low +0.001 % Change From 1 Year Low (%) +33.33
Change From 1 Year High -0.015 % Change From 1 Year High (%) -78.95
2 Years Range 0.003 - 0.040 Change From 2 Years Low +0.001 % Change From 2 Years Low (%) +33.33
Change From 2 Years High -0.036 % Change From 2 Years High (%) -90.00
5 Years Range 0.003 - 0.560 Change From 5 Years Low +0.001 % Change From 5 Years Low (%) +33.33
Change From 5 Years High -0.556 % Change From 5 Years High (%) -99.29
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The Group collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

IPO Performance

Listing Date 29 Apr 2014 Full Subscription Rate (x) -
No of Placement Shares (M) 196.43 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.340 First Week Close (SGD) 0.345
Current vs IPO Price (%) -98.57 First Day Gain (%) +21.43 First Week Gain (%) +23.21

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(1.05 MB)
Part 2(0.10 MB)
Annual Report 2017 Dec 2017 Part 1(0.91 MB)
Part 2(0.08 MB)
Annual Report 2016 Dec 2016 Part 1(1.60 MB)
Part 2(0.47 MB)
Annual Report 2015 Dec 2015 Part 1(0.82 MB)
Part 2(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(2.05 MB)
Part 2(0.42 MB)
Annual Report 2013 Dec 2013 Part 1(1.04 MB)
IPO Prospectus
IPO Prospectus 2014 Apr 2014 Part 1(3.55 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
23 Apr 2019 0.004 0.004 0.004 0.004 4,250,000 0.0040
22 Apr 2019 0.004 0.004 0.004 0.004 2,922,100 0.0040
18 Apr 2019 0.004 0.004 0.004 0.004 4,482,000 0.0040
17 Apr 2019 0.004 0.005 0.004 0.005 6,094,500 0.0040
16 Apr 2019 0.004 0.005 0.004 0.004 18,335,500 0.0040
15 Apr 2019 0.004 0.005 0.004 0.004 18,231,300 0.0041
12 Apr 2019 0.003 0.004 0.003 0.004 9,203,000 0.0040
11 Apr 2019 0.003 0.003 0.003 0.003 370,000 0.0030
10 Apr 2019 0.003 0.004 0.003 0.003 1,700,000 0.0031
09 Apr 2019 0.003 0.004 0.003 0.004 1,689,000 0.0036
08 Apr 2019 0.004 0.004 0.004 0.004 723,000 0.0040
05 Apr 2019 0.004 0.004 0.004 0.004 4,409,000 0.0040
04 Apr 2019 0.004 0.004 0.003 0.004 4,900,300 0.0031
03 Apr 2019 0.003 0.004 0.003 0.004 1,660,000 0.0040
02 Apr 2019 0.003 0.003 0.003 0.003 1,602,300 0.0030
01 Apr 2019 0.003 0.004 0.003 0.003 3,788,500 0.0031
29 Mar 2019 0.004 0.004 0.003 0.003 11,240,000 0.0035
28 Mar 2019 0.005 0.005 0.004 0.004 106,455,900 0.0040
27 Mar 2019 0.005 0.005 0.004 0.004 1,850,000 0.0044
26 Mar 2019 0.005 0.005 0.005 0.005 8,088,000 0.0050
25 Mar 2019 0.005 0.006 0.004 0.005 69,542,500 0.0050
22 Mar 2019 0.006 0.006 0.006 0.006 28,900,400 0.0060
Summary
Current 2 Weeks
(09 Apr 2019 to 23 Apr 2019)
0.003 0.005 0.003 0.004 67,277,400 -
Previous 2 Weeks
(26 Mar 2019 to 08 Apr 2019)
0.005 0.005 0.003 0.004 144,717,000 -
4 Weeks from
(26 Feb 2019 to 25 Mar 2019)
0.007 0.007 0.003 0.005 199,327,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.